Fig. 3From: Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH)Reactogenicity symptoms 1-week post-3rd BNT162b2 COVID-19 vaccine booster in People living with HIV, aged ≥55 yearsBack to article page